Results 131 to 140 of about 3,199 (152)

Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria

Rheumatology, 2012
To compare Ankylosing Spondylitis Disease Activity Score (ASDAS) ≥2.1 with BASDAI >4 as an eligibility criterion for initiation of TNF inhibitor (TNFi) treatment in AS, and to investigate if ASDAS performs satisfactorily in patients without elevated CRP or without peripheral joint swelling.Two hundred and eighty-nine patients starting their first TNFi ...
Fagerli, K.M., Lie, E., Heijde, D. van der, Heiberg, M.S., Kaufmann, C., Rodevand, E., Mikkelsen, K., Kalstad, S., Kvien, T.K.   +8 more
openaire   +3 more sources

THU0196 Is the Basdai Score Driven by Pain in Ankylosing Spondylitis Patients Treated with Anti-TNF?

Annals of the Rheumatic Diseases, 2015
Background The present standard for measuring disease activity in Ankylosing Spondylitis (AS) is the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) which focuses on five major symptoms including fatigue, axial pain, peripheral pain, enthesitis and morning stiffness (severity and duration).
P. Rahman, A. Jovaisas, W. Bensen, W. Olszynski, A. Jaroszynska, P. Baer, M. Sheriff, D. Sholter, E. Psaradellis, J.S. Sampalis, F. Nantel, S. Otawa, A.J. Lehman, C. Tkaczyk, M. Shawi   +14 more
openaire   +1 more source

Is it time to replace BASDAI with ASDAS?

Nature Reviews Rheumatology, 2013
Machado, P., Landewe, R.
openaire   +4 more sources

VALIDITY OF ASDAS AND BASDAI AS A MEASURE OF DISEASE ACTIVITY IN AXIAL PSORIATIC ARTHRITIS

2014
[Abstract Not Available]
Kilic, G., Kilic, E., Nas, K., Karkucak, M., Capkin, E., Dagli, A. Z., Cevik, R.   +6 more
openaire   +3 more sources

[Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis].

Reumatizam, 2015
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) is the most frequently used ankylosing spondylitis activity assesment by which through 6 questions 5 basic diseases symptoms (fatigue, back pain, joint pain/swelling, enthesitic points, intensity and duration of morning stiffness) are being evaluated.
Dubravka, Bobek, Iva, Zagar, Kristina, Kovač-Durmiš, Porin, Perić, Božidar, Ćurković, Ðurđica, Babić-Naglić   +5 more
openaire   +1 more source

E100 Comparison between BASDAI and ASDAS c-reactive protein scores in spondyloarthritis

Rheumatology
Abstract Background/Aims The choice between evaluation indices for disease activity in spondyloarthritis (SpA) in daily practice can be challenging due to the highly heterogeneous clinical expression of the disease.
Mohammed Khalil Jnyah, Imane El Mezouar, Nessrine Akasbi, Taoufik Harzy   +3 more
openaire   +1 more source

BASDAI cut-off values corresponding to ASDAS cut-off values

Rheumatology, 2022
Oh Chan Kwon, Min-Chan Park
exaly  

AB0873 Ethnicity and patient reported outcome BASDAI in the monitoring of axial spondyloarthropathy: Does it matter?

Annals of the Rheumatic Diseases, 2022
S. Byravan, S. Jothimurugan, A. Moorthy
openaire   +1 more source

Ethnicity and patient reported outcome BASDAI in the monitoring of axial spondyloarthropathy: Does it matter?

Musculoskeletal Care, 2023
Arumugam Moorthy, Swetha Byravan
exaly  

Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?

Arthritis and Rheumatism, 2004
William Taylor, Andrew Harrison
exaly